BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 22232276)

  • 1. Determinants of quinolone versus trimethoprim-sulfamethoxazole use for outpatient urinary tract infection.
    Stuck AK; Täuber MG; Schabel M; Lehmann T; Suter H; Mühlemann K
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1359-63. PubMed ID: 22232276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections.
    Gupta K; Hooton TM; Stamm WE
    Ann Intern Med; 2001 Jul; 135(1):41-50. PubMed ID: 11434731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes associated with trimethoprim/sulphamethoxazole (TMP/SMX) therapy in TMP/SMX resistant community-acquired UTI.
    Gupta K; Stamm WE
    Int J Antimicrob Agents; 2002 Jun; 19(6):554-6. PubMed ID: 12135847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The current management strategies for community-acquired urinary tract infection.
    Hooton TM
    Infect Dis Clin North Am; 2003 Jun; 17(2):303-32. PubMed ID: 12848472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Addressing antibiotic resistance.
    Gupta K
    Dis Mon; 2003 Feb; 49(2):99-110. PubMed ID: 12601340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Seven-Day Course of TMP-SMX May Be as Effective as a Seven-Day Course of Ciprofloxacin for the Treatment of Pyelonephritis.
    Fox MT; Melia MT; Same RG; Conley AT; Tamma PD
    Am J Med; 2017 Jul; 130(7):842-845. PubMed ID: 28216442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Factors for Trimethoprim and Sulfamethoxazole-Resistant Escherichia Coli in ED Patients with Urinary Tract Infections.
    Wesolek JL; Wu JY; Smalley CM; Wang L; Campbell MJ
    Am J Emerg Med; 2022 Jun; 56():178-182. PubMed ID: 35405469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoroquinolones in the treatment of acute uncomplicated urinary tract infections in adult women.
    Garrison J; Hooton TM
    Expert Opin Pharmacother; 2001 Aug; 2(8):1227-37. PubMed ID: 11584990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Empiric use of trimethoprim-sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP-SMX-resistant uropathogens.
    Raz R; Chazan B; Kennes Y; Colodner R; Rottensterich E; Dan M; Lavi I; Stamm W;
    Clin Infect Dis; 2002 May; 34(9):1165-9. PubMed ID: 11941541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outpatient antibiogram and predictors of ciprofloxacin and trimethoprim-sulfamethoxazole resistant urinary tract infections.
    Valentine-King M; Zoorob R; Grigoryan L; Trautner B
    Ann Fam Med; 2022 Apr; 20(20 Suppl 1):. PubMed ID: 36944052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing adherence to evidence-based guidelines for the diagnosis and management of uncomplicated urinary tract infection.
    Grover ML; Bracamonte JD; Kanodia AK; Bryan MJ; Donahue SP; Warner AM; Edwards FD; Weaver AL
    Mayo Clin Proc; 2007 Feb; 82(2):181-5. PubMed ID: 17290725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trimethoprim-sulfamethoxazole resistance among urinary coliform isolates.
    Wright SW; Wrenn KD; Haynes ML
    J Gen Intern Med; 1999 Oct; 14(10):606-9. PubMed ID: 10571705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addressing antibiotic resistance.
    Gupta K
    Am J Med; 2002 Jul; 113 Suppl 1A():29S-34S. PubMed ID: 12113869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of trimethoprim-sulfamethoxazole as Pneumocystis jiroveci pneumonia prophylaxis on the occurrence of asymptomatic bacteriuria and urinary tract infections among renal allograft recipients: a retrospective before-after study.
    Singh R; Bemelman FJ; Hodiamont CJ; Idu MM; Ten Berge IJ; Geerlings SE
    BMC Infect Dis; 2016 Feb; 16():90. PubMed ID: 26912326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The comeback of trimethoprim in France.
    Caron F; Wehrle V; Etienne M
    Med Mal Infect; 2017 Jun; 47(4):253-260. PubMed ID: 28043762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of enoxacin versus trimethoprim-sulfamethoxazole in the treatment of patients with complicated urinary tract infection.
    Gottlieb PL
    Clin Ther; 1995; 17(3):493-502. PubMed ID: 7585853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic resistance in isolates recovered from women with community-acquired urinary tract infections presenting to a tertiary care emergency department.
    Filiatrault L; McKay RM; Patrick DM; Roscoe DL; Quan G; Brubacher J; Collins KM
    CJEM; 2012 Sep; 14(5):295-305. PubMed ID: 22967697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility of the Index Urinary Tract Infection to Prophylactic Antibiotics Is a Predictive Factor of Breakthrough Urinary Tract Infection in Children with Primary Vesicoureteral Reflux Receiving Continuous Antibiotic Prophylaxis.
    Lee JN; Byeon KH; Woo MJ; Baek HS; Cho MH; Jeong SY; Lee SM; Ham JY; Ha YS; Kim HT; Yoo ES; Kwon TG; Chung SK
    J Korean Med Sci; 2019 Jun; 34(21):e156. PubMed ID: 31144480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uncomplicated urinary tract infections: lomefloxacin versus trimethoprim/sulphamethoxazole.
    Guibert J; Capron MH
    J Int Med Res; 1992 Nov; 20(6):467-74. PubMed ID: 1337525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized clinical trial of rifampin-trimethoprim and sulfamethoxazole-trimethoprim in the treatment of localized urinary tract infections.
    Stein GE; Gurwith D; Gurwith M
    Antimicrob Agents Chemother; 1988 Jun; 32(6):802-6. PubMed ID: 3046481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.